Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Author index

Page Path
HOME > Browse Articles > Author index
Search
James Edward Dixon 1 Article
The Outcome of Endoscopic Radiofrequency Anti-Reflux Therapy (STRETTA) for Gastroesophageal Reflux Disease in Patients with Previous Gastric Surgery: A Prospective Cohort Study
Edward John Nevins, James Edward Dixon, Yirupaiahgari Krishnaiah Setty Viswanath
Clin Endosc 2021;54(4):542-547.   Published online March 24, 2021
DOI: https://doi.org/10.5946/ce.2020.243
AbstractAbstract PDFPubReaderePub
Background
/Aims: STRETTA improves the quality of life and reduces the need for anti-reflux medication in select patients, especially those with uncomplicated gastroesophageal reflux disease (GERD). We aimed to review the outcomes of STRETTA in patients with medically refractory GERD, who had undergone previous gastric surgery.
Methods
This was a review of a prospective database in a British center. Since 2016, all GERD patients who underwent STRETTA and had a history of previous gastric surgery were studied (n=11). Anti-reflux medication pre- and post-STRETTA was evaluated. The outcomes were assessed objectively by the change in anti-reflux medication and subjectively through a pre- and post-procedure GERD-health-related quality of life (HRQL) questionnaire.
Results
The median length of follow-up was 23 months. Nine patients demonstrated improved GERD-HRQL scores following STRETTA (82%). Of the 7 patients who underwent fundoplication, all reported improved symptoms, with 3 patients discontinuing the medication and 3 patients on a reduced dose of proton pump inhibitor. Four patients underwent surgery other than fundoplication, of which 2 reported improvement and discontinued the proton pump inhibitor. Two patients reported no improvement.
Conclusions
This study demonstrates that STRETTA is successful in reducing refractory GERD in patients with previous gastric surgery. The outcomes were comparable to published outcomes in patients with uncomplicated GERD with no previous history of gastric surgery.

Citations

Citations to this article as recorded by  
  • The Need for Updated Classification of Esophageal Motility Disorders Using High-resolution Impedance Manometry
    Sung Eun Kim
    Journal of Neurogastroenterology and Motility.2024; 30(1): 1.     CrossRef
  • Endoscopic radiofrequency Stretta therapy reduces proton pump inhibitor dependency and the need for anti-reflux surgery for refractory gastroesophageal reflux disease
    Abraham Joel, Alakh Konjengbam, Yirupaiahgari Viswanath, Georgios Kourounis, Emily Hammond, Helen Frank, Shivani Kuttuva, Simon Mbarushimana, Hena Hidayat, Srivishnu Thulasiraman
    Clinical Endoscopy.2024; 57(1): 58.     CrossRef
  • Long-term efficacy of endoscopic radiofrequency Stretta therapy for patients with refractory gastroesophageal reflux disease
    Sung Eun Kim
    Clinical Endoscopy.2024; 57(1): 48.     CrossRef
  • Endoscopic Non-ablative Radiofrequency Treatment (Stretta) for Gastroesophageal Reflux Disease (GERD)
    George Triadafilopoulos
    Current Gastroenterology Reports.2024; 26(4): 93.     CrossRef
  • Endoscopic Management Options for Gastroesophageal Reflux Disease
    Bhavana Sreepad, Karteek Chennupati, Muhammad Shehroz Zeeshan, Zeeshan Ramzan
    Cureus.2024;[Epub]     CrossRef
  • In Which Situation is Endoscopic Radiofrequency Anti-Reflux Therapy (Stretta) Effective for Controlling Gastroesophageal Reflux Symptoms?
    Hwoon-Yong Jung
    Clinical Endoscopy.2021; 54(4): 451.     CrossRef
  • Endoscopic Treatment of GERD in Patients With Obesity
    Rabih Ghazi, Babusai Rapaka, Barham K. Abu Dayyeh
    Foregut: The Journal of the American Foregut Society.2021; 1(4): 336.     CrossRef
  • 4,483 View
  • 130 Download
  • 4 Web of Science
  • 7 Crossref
Close layer

Clin Endosc : Clinical Endoscopy Twitter Facebook
Close layer
TOP